JPMA Guidelines: Public Release Of Doctors Lecture Fees Desired
This article was originally published in PharmAsia News
According to transparency guidelines released by the Japan Pharmaceutical Manufacturers Association, lecture and manuscript fees paid by pharmaceutical companies to individual doctors should be published not only on company websites but also in locations specified by each company.
You may also be interested in...
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.
The apparently first-ever FDA press release for an advertising warning letter underscores importance of opioid issues – and the agency’s changing approach to media relations in general. FDA objects to Alkermes journal ad that excludes risk information about its opioid dependence treatment drug.